Marina Botto

Active 1990–2024

93
Papers
19,108
Citations
79
h-index
92
i10-index

Citations

Citations per year for Marina Botto1991: 2 citations1992: 1 citations1993: 3 citations1994: 2 citations1995: 2 citations1996: 3 citations1997: 4 citations1998: 24 citations1999: 35 citations2000: 84 citations2001: 134 citations2002: 142 citations2003: 154 citations2004: 246 citations2005: 205 citations2006: 248 citations2007: 228 citations2008: 253 citations2009: 278 citations2010: 249 citations2011: 237 citations2012: 265 citations2013: 192 citations2014: 182 citations2015: 191 citations2016: 191 citations2017: 168 citations2018: 156 citations2019: 516 citations2020: 468 citations2021: 511 citations2022: 466 citations2023: 350 citations2024: 468 citations2025: 244 citations2026: 3 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,255 citing papers, 27.5% of this breakdownUnited Kingdom: 1,008 citing papers, 12.3% of this breakdownChina: 681 citing papers, 8.3% of this breakdownGermany: 511 citing papers, 6.2% of this breakdownItaly: 432 citing papers, 5.3% of this breakdownFrance: 365 citing papers, 4.4% of this breakdownNetherlands: 290 citing papers, 3.5% of this breakdownCanada: 232 citing papers, 2.8% of this breakdownJapan: 216 citing papers, 2.6% of this breakdownSwitzerland: 203 citing papers, 2.5% of this breakdownAustralia: 185 citing papers, 2.2% of this breakdownSweden: 170 citing papers, 2.1% of this breakdown
0%27.5%Other 20.3%

Fields

  • Immunology and Microbiology44%
  • Medicine36.8%
  • Biochemistry, Genetics and Molecular Biology12.4%
  • Neuroscience4%
  • Agricultural and Biological Sciences1%
  • Materials Science0.5%
  • Other1.3%

Topics

  • Complement system in diseases6.9%
  • Immune Cell Function and Interaction4.5%
  • T-cell and B-cell Immunology4%
  • Systemic Lupus Erythematosus Research3.1%
  • Phagocytosis and Immune Regulation3.1%
  • Monoclonal and Polyclonal Antibodies Research2.5%
  • Other75.9%

Coauthors

All papers

Open in search
  1. Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor Growth

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xavier Cathelineau, Catherine Sautès‐Fridman, Wolf H. Fridman - Cancer Immunology Research 2019 cited by 274

  2. Dectin-1 is required for β-glucan recognition and control of fungal infection

    Authors: , , , , , , , , , , - Nature Immunology 2006 cited by 1,148

  3. C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation

    Authors: , , , , , , , , , - Nature Communications 2016 cited by 295

  4. Tissue-Restricted Adaptive Type 2 Immunity Is Orchestrated by Expression of the Costimulatory Molecule OX40L on Group 2 Innate Lymphoid Cells

    Authors: , , , , , , , , , , , , , , , - Immunity 2018 cited by 242

  5. Reversible CD8 T cell–neuron cross-talk causes aging-dependent neuronal regenerative decline

    Authors: , , , , , , , , , , , , , , , , , , - Science 2022 cited by 112

  6. Type I interferons affect the metabolic fitness of CD8+ T cells from patients with systemic lupus erythematosus

    Authors: , , , , , , , , , , - Nature Communications 2021 cited by 113

  7. PD-1 blockade improves Kupffer cell bacterial clearance in acute liver injury

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2020 cited by 110

  8. C1q restrains autoimmunity and viral infection by regulating CD8 + T cell metabolism

    Authors: , , , , , , , , , , , - Science 2018 cited by 192

  9. Microbial-driven preterm labour involves crosstalk between the innate and adaptive immune response

    Authors: , , , , , , , , , , , , , , , , , - Nature Communications 2022 cited by 112

  10. Recognition and control of neutrophil extracellular trap formation by MICL

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cosimo De Bari, Janet A. Willment, Gordon D. Brown - Nature 2024 cited by 59

  11. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies

    Authors: , , , , , , , , - Nature Genetics 1998 cited by 1,414

  12. Absence of C1q Leads to Less Neuropathology in Transgenic Mouse Models of Alzheimer's Disease

    Authors: , , , - Journal of Neuroscience 2004 cited by 348

  13. C1q as a unique player in angiogenesis with therapeutic implication in wound healing

    Authors: , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 157

  14. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response

    Authors: , , , , , , , , , , , , , , , , , , , - Nature 2002 cited by 674

  15. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H

    Authors: , , , , , , - Nature Genetics 2002 cited by 506

  16. Autophagy is activated in systemic lupus erythematosus and required for plasmablast development

    Authors: , , , , , , - Annals of the Rheumatic Diseases 2014 cited by 249

  17. Complement alone drives efficacy of a chimeric antigonococcal monoclonal antibody

    Authors: , , , , , , , , , , , , , , , , - PLoS Biology 2019 cited by 94

  18. Complement C1q Activates Canonical Wnt Signaling and Promotes Aging-Related Phenotypes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cell 2012 cited by 323

  19. Serum amyloid P component is an essential element of resistance against Aspergillus fumigatus

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2021 cited by 76

  20. Systemic Lupus Erythematosus, Complement Deficiency, and Apoptosis

    Authors: , , , , - Advances in immunology 2001 cited by 538

  21. Complement C1q Reduces Early Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice

    Authors: , , , , , , , - American Journal Of Pathology 2007 cited by 163

  22. Multi-omics identify falling LRRC15 as a COVID-19 severity marker and persistent pro-thrombotic signals in convalescence

    Authors: , , , , , , , , , , , , , , , , - Nature Communications 2022 cited by 36

  23. Complement Activation Determines the Therapeutic Activity of Rituximab In Vivo

    Authors: , , , , , , , , - The Journal of Immunology 2003 cited by 563

  24. Hyposialylated IgG activates endothelial IgG receptor FcγRIIB to promote obesity-induced insulin resistance

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2017 cited by 109